<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>27(1)</volume><submitter>Munoz-Vendrell A</submitter><journal>The journal of headache and pain</journal><pagination>2</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12764079</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response.</pubmed_title><pmcid>PMC12764079</pmcid><pubmed_authors>Guerrero-Peral AL</pubmed_authors><pubmed_authors>Layos-Romero A</pubmed_authors><pubmed_authors>Diaz-de-Teran J</pubmed_authors><pubmed_authors>Caronna E</pubmed_authors><pubmed_authors>Valin-Villanueva P</pubmed_authors><pubmed_authors>Garcia-Azorin D</pubmed_authors><pubmed_authors>Munoz-Vendrell A</pubmed_authors><pubmed_authors>Morollon Sanchez-Mateos N</pubmed_authors><pubmed_authors>Campdelacreu J</pubmed_authors><pubmed_authors>Alpuente A</pubmed_authors><pubmed_authors>Santos-Lasaosa S</pubmed_authors><pubmed_authors>Belvis R</pubmed_authors><pubmed_authors>Minguez-Olaondo A</pubmed_authors><pubmed_authors>Garcia Sanchez SM</pubmed_authors><pubmed_authors>Perez-de-la-Parte A</pubmed_authors><pubmed_authors>Pozo-Rosich P</pubmed_authors><pubmed_authors>Sanchez-Soblechero A</pubmed_authors><pubmed_authors>Gonzalez-Garcia N</pubmed_authors><pubmed_authors>Casas-Limon J</pubmed_authors><pubmed_authors>Torres-Ferrus M</pubmed_authors><pubmed_authors>Gonzalez-Martinez A</pubmed_authors><pubmed_authors>Morales Hernandez C</pubmed_authors><pubmed_authors>Fernandez-Lazaro I</pubmed_authors><pubmed_authors>Cano Sanchez LM</pubmed_authors><pubmed_authors>Gago-Veiga AB</pubmed_authors><pubmed_authors>Gonzalez Osorio Y</pubmed_authors><pubmed_authors>Portocarrero-Sanchez L</pubmed_authors><pubmed_authors>Lopez-Bravo A</pubmed_authors><pubmed_authors>Campoy-Diaz S</pubmed_authors><pubmed_authors>Lozano Ros A</pubmed_authors><pubmed_authors>Andres Lopez A</pubmed_authors><pubmed_authors>Huerta-Villanueva M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response.</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-06T10:43:49.157Z</modification><creation>2026-05-29T03:12:49.286Z</creation></dates><accession>S-EPMC12764079</accession><cross_references><pubmed>41315923</pubmed><doi>10.1186/s10194-025-02239-1</doi></cross_references></HashMap>